Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Recombinant ChAdOx1-S
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved
Sponsor : AstraZeneca
Deal Size : Undisclosed
Deal Type : Agreement
AstraZeneca, Nipro Sign COVID-19 Vaccine Deal for Supply in Japan
Details : Nipro Corporation has entered into a Contract Manufacturing Agreement with AstraZeneca K.K. for the fill and finish process of AstraZeneca's COVID-19 vaccine, "Vaxzevria™ intramuscular injection".
Brand Name : Vaxzevria
Molecule Type : Vaccine
Upfront Cash : Undisclosed
May 26, 2021
Lead Product(s) : Recombinant ChAdOx1-S
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Sponsor : AstraZeneca
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?